Active Sites Display

WP_058694945.1:FCLGBLEE_02323 Job run log
Sequence length: 1049 aa
4 domain hit(s)
This protein was scanned against CAZyme family profile alignments to identify conserved domains. Each hit below shows a region of the query that aligns to a known CAZyme family. Within each family profile, certain residues are known or predicted to be catalytic — directly involved in the enzyme's chemical reaction. The sequence display compares these critical positions between the query protein and the family consensus:
Match: the query has the expected catalytic residue, suggesting this active site is conserved and likely functional.
Mismatch: the query has a different residue at this position, which may indicate altered activity, a non-functional site, or subfamily variation.
Gap: the catalytic position in the profile has no corresponding residue in the query alignment, suggesting a deletion or truncation in this region.
Match
Mismatch
Gap
Active Site Conservation Analysis
EntryClassNameDomain RangeCoverageConservationCat. SitesMatches
PF16561CBMGlycogen recognition site of AMP-activated protein kinase1–104072.7%40.7%132
IPR000514GHGlycoside hydrolase, family 391–104994.4%50%11
IPR006101GHGlycoside hydrolase, family 21017–1032100%42.9%21
IPR006215GHGlycoside hydrolase, melibiase48–6187.5%40%82
Domain coverage (1–1049 aa)
PF16561 — Glycogen recognition site of AMP-activated protein kinase (domain 1–1040)
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 471 481 491 501 511 521 531 541 551 561 571 581 591 601 611 621 631 641 651 661 671 681 691 701 711 721 731 741 751 761 771 781 791 801 811 821 831 841 851 861 871 881 891 901 911 921 931 941 951 961 971 981 991 1001 1011 1021 1031 1041 Query: MRKKWKKLLT ACLTAVLLMS GLCPAVSAAG EEQRVLRVAF PESKGINEVY EDGTYGGCVY DWLQEIAKYT GWKYEFVTGN ADSLYDEFVE GKYDLMGGMY KVEGYTEAYN FPKYIMGSNN SLLIYRNNDE SIRSFDSSTL NGKRIGVYKM ATAKIERLQK YLDFNSLSCE LVPYDNVKEY EKCLETDRVD LMLGSEVYMK DGYNVAAKFD TEPYYIVTAK NEPGLCDELS AAMEAIYAAN PNFAKEVYEK YFPDSYVNAI TFTEGERRFI EQSGPIRVSV IRDKYPLHYE ENGAYVGIIP SCLELITKRT GLTFEYVYGD SYKELLELVQ TGKADIASWF TNGDYSAASM GLVRTARFAT LDTVMLRNKQ SAETGTGQVM ALPERMDNKP ASEKDSVRYY QNYEACMEAV DRGEADYTTI PAAFMEDLYA QNYYPNIYLV ADMNAPEELT LALSDPVNVP LYSVLSKAIN NLSDEERETI RLQNSLSIRE GSVSLKSLLY GNPVLFISIC VGIIALAAAV LLLFNFYHTK EKVMRIELEK AVETSKAKSD FLSRMSHEIR TPMNGIMGMT AIAQQNVDDR EKTAECLEKV EASSKHLLSL INDILDMSKI ESGKVEFRHV LFDFREVLGE ICDTYYGQAE EKNIQFETLL VGSVPEKLTG DPLRLRQIVG NLLSNACKFT PEGGRVELRV SELSKGDEAI WLSFEVTDTG CGIARENVDH IFESFEQADA DITANYGGTG LGLSIVRNFT EAMGGTVDVA SEEGLGSTFC IELPFGNPGQ PQPAFDSQGM SALVLARESE VGRHIALVLE SLGIQTDTVS SLEKARALAL QGKAYPLYFV DGRLQNAEAL ETVRRIRALI GDEAGLYLLT TSRMTGLKKE AAAAGATGVI LRPLFPSNIA EALAAGEPER GGQEAEKSWD FSGYRILLAE DNEINREIAC ELLSVTGATV DTAVDGQEAL NKFAAAAVGC YDLILMDIQM PVMDGHEATR RIRALGRPDS ATVPIFAMTA NAFTDDVNKS LESGMNGHIS KPLDVSVLYE KIRAAIQPD Profile: ·······H·· ·········· ·········· ·········· ·········· ·········· ·······KDD ····K···N· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· D········· ·······D·· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········N N·······D· ·········
query > profileL8>H10gap>E32gap>N55K68>K56Y69>D57T70>D58E75>K63G79>N67D841>D68A858>D85S1030>N89K1031>N90Y1039>D98
IPR000514 — Glycoside hydrolase, family 39 (domain 1–1049)
Cross-ref: InterPro: IPR000514
GO: GO:0004553 hydrolase activity, hydrolyzing O-glycosyl compoundsGO:0005975 carbohydrate metabolic process
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 471 481 491 501 511 521 531 541 551 561 571 581 591 601 611 621 631 641 651 661 671 681 691 701 711 721 731 741 751 761 771 781 791 801 811 821 831 841 851 861 871 881 891 901 911 921 931 941 951 961 971 981 991 1001 1011 1021 1031 1041 Query: MRKKWKKLLT ACLTAVLLMS GLCPAVSAAG EEQRVLRVAF PESKGINEVY EDGTYGGCVY DWLQEIAKYT GWKYEFVTGN ADSLYDEFVE GKYDLMGGMY KVEGYTEAYN FPKYIMGSNN SLLIYRNNDE SIRSFDSSTL NGKRIGVYKM ATAKIERLQK YLDFNSLSCE LVPYDNVKEY EKCLETDRVD LMLGSEVYMK DGYNVAAKFD TEPYYIVTAK NEPGLCDELS AAMEAIYAAN PNFAKEVYEK YFPDSYVNAI TFTEGERRFI EQSGPIRVSV IRDKYPLHYE ENGAYVGIIP SCLELITKRT GLTFEYVYGD SYKELLELVQ TGKADIASWF TNGDYSAASM GLVRTARFAT LDTVMLRNKQ SAETGTGQVM ALPERMDNKP ASEKDSVRYY QNYEACMEAV DRGEADYTTI PAAFMEDLYA QNYYPNIYLV ADMNAPEELT LALSDPVNVP LYSVLSKAIN NLSDEERETI RLQNSLSIRE GSVSLKSLLY GNPVLFISIC VGIIALAAAV LLLFNFYHTK EKVMRIELEK AVETSKAKSD FLSRMSHEIR TPMNGIMGMT AIAQQNVDDR EKTAECLEKV EASSKHLLSL INDILDMSKI ESGKVEFRHV LFDFREVLGE ICDTYYGQAE EKNIQFETLL VGSVPEKLTG DPLRLRQIVG NLLSNACKFT PEGGRVELRV SELSKGDEAI WLSFEVTDTG CGIARENVDH IFESFEQADA DITANYGGTG LGLSIVRNFT EAMGGTVDVA SEEGLGSTFC IELPFGNPGQ PQPAFDSQGM SALVLARESE VGRHIALVLE SLGIQTDTVS SLEKARALAL QGKAYPLYFV DGRLQNAEAL ETVRRIRALI GDEAGLYLLT TSRMTGLKKE AAAAGATGVI LRPLFPSNIA EALAAGEPER GGQEAEKSWD FSGYRILLAE DNEINREIAC ELLSVTGATV DTAVDGQEAL NKFAAAAVGC YDLILMDIQM PVMDGHEATR RIRALGRPDS ATVPIFAMTA NAFTDDVNKS LESGMNGHIS KPLDVSVLYE KIRAAIQPD Profile: ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ···D······ ·········
query > profileD1034>D3
IPR006101 — Glycoside hydrolase, family 2 (domain 1017–1032)
Cross-ref: InterPro: IPR006101
GO: GO:0004553 hydrolase activity, hydrolyzing O-glycosyl compoundsGO:0005975 carbohydrate metabolic process
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 471 481 491 501 511 521 531 541 551 561 571 581 591 601 611 621 631 641 651 661 671 681 691 701 711 721 731 741 751 761 771 781 791 801 811 821 831 841 851 861 871 881 891 901 911 921 931 941 951 961 971 981 991 1001 1011 1021 1031 1041 Query: MRKKWKKLLT ACLTAVLLMS GLCPAVSAAG EEQRVLRVAF PESKGINEVY EDGTYGGCVY DWLQEIAKYT GWKYEFVTGN ADSLYDEFVE GKYDLMGGMY KVEGYTEAYN FPKYIMGSNN SLLIYRNNDE SIRSFDSSTL NGKRIGVYKM ATAKIERLQK YLDFNSLSCE LVPYDNVKEY EKCLETDRVD LMLGSEVYMK DGYNVAAKFD TEPYYIVTAK NEPGLCDELS AAMEAIYAAN PNFAKEVYEK YFPDSYVNAI TFTEGERRFI EQSGPIRVSV IRDKYPLHYE ENGAYVGIIP SCLELITKRT GLTFEYVYGD SYKELLELVQ TGKADIASWF TNGDYSAASM GLVRTARFAT LDTVMLRNKQ SAETGTGQVM ALPERMDNKP ASEKDSVRYY QNYEACMEAV DRGEADYTTI PAAFMEDLYA QNYYPNIYLV ADMNAPEELT LALSDPVNVP LYSVLSKAIN NLSDEERETI RLQNSLSIRE GSVSLKSLLY GNPVLFISIC VGIIALAAAV LLLFNFYHTK EKVMRIELEK AVETSKAKSD FLSRMSHEIR TPMNGIMGMT AIAQQNVDDR EKTAECLEKV EASSKHLLSL INDILDMSKI ESGKVEFRHV LFDFREVLGE ICDTYYGQAE EKNIQFETLL VGSVPEKLTG DPLRLRQIVG NLLSNACKFT PEGGRVELRV SELSKGDEAI WLSFEVTDTG CGIARENVDH IFESFEQADA DITANYGGTG LGLSIVRNFT EAMGGTVDVA SEEGLGSTFC IELPFGNPGQ PQPAFDSQGM SALVLARESE VGRHIALVLE SLGIQTDTVS SLEKARALAL QGKAYPLYFV DGRLQNAEAL ETVRRIRALI GDEAGLYLLT TSRMTGLKKE AAAAGATGVI LRPLFPSNIA EALAAGEPER GGQEAEKSWD FSGYRILLAE DNEINREIAC ELLSVTGATV DTAVDGQEAL NKFAAAAVGC YDLILMDIQM PVMDGHEATR RIRALGRPDS ATVPIFAMTA NAFTDDVNKS LESGMNGHIS KPLDVSVLYE KIRAAIQPD Profile: ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·····N···· ·Y········ ·········
query > profileN1026>N10P1032>Y16
IPR006215 — Glycoside hydrolase, melibiase (domain 48–61)
Cross-ref: InterPro: IPR006215
GO: GO:0004557 alpha-galactosidase activityGO:0005975 carbohydrate metabolic process
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 471 481 491 501 511 521 531 541 551 561 571 581 591 601 611 621 631 641 651 661 671 681 691 701 711 721 731 741 751 761 771 781 791 801 811 821 831 841 851 861 871 881 891 901 911 921 931 941 951 961 971 981 991 1001 1011 1021 1031 1041 Query: MRKKWKKLLT ACLTAVLLMS GLCPAVSAAG EEQRVLRVAF PESKGINEVY EDGTYGGCVY DWLQEIAKYT GWKYEFVTGN ADSLYDEFVE GKYDLMGGMY KVEGYTEAYN FPKYIMGSNN SLLIYRNNDE SIRSFDSSTL NGKRIGVYKM ATAKIERLQK YLDFNSLSCE LVPYDNVKEY EKCLETDRVD LMLGSEVYMK DGYNVAAKFD TEPYYIVTAK NEPGLCDELS AAMEAIYAAN PNFAKEVYEK YFPDSYVNAI TFTEGERRFI EQSGPIRVSV IRDKYPLHYE ENGAYVGIIP SCLELITKRT GLTFEYVYGD SYKELLELVQ TGKADIASWF TNGDYSAASM GLVRTARFAT LDTVMLRNKQ SAETGTGQVM ALPERMDNKP ASEKDSVRYY QNYEACMEAV DRGEADYTTI PAAFMEDLYA QNYYPNIYLV ADMNAPEELT LALSDPVNVP LYSVLSKAIN NLSDEERETI RLQNSLSIRE GSVSLKSLLY GNPVLFISIC VGIIALAAAV LLLFNFYHTK EKVMRIELEK AVETSKAKSD FLSRMSHEIR TPMNGIMGMT AIAQQNVDDR EKTAECLEKV EASSKHLLSL INDILDMSKI ESGKVEFRHV LFDFREVLGE ICDTYYGQAE EKNIQFETLL VGSVPEKLTG DPLRLRQIVG NLLSNACKFT PEGGRVELRV SELSKGDEAI WLSFEVTDTG CGIARENVDH IFESFEQADA DITANYGGTG LGLSIVRNFT EAMGGTVDVA SEEGLGSTFC IELPFGNPGQ PQPAFDSQGM SALVLARESE VGRHIALVLE SLGIQTDTVS SLEKARALAL QGKAYPLYFV DGRLQNAEAL ETVRRIRALI GDEAGLYLLT TSRMTGLKKE AAAAGATGVI LRPLFPSNIA EALAAGEPER GGQEAEKSWD FSGYRILLAE DNEINREIAC ELLSVTGATV DTAVDGQEAL NKFAAAAVGC YDLILMDIQM PVMDGHEATR RIRALGRPDS ATVPIFAMTA NAFTDDVNKS LESGMNGHIS KPLDVSVLYE KIRAAIQPD Profile: ·········· ·········· ·········· ·········· ·······NCY NK······SY ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········
query > profileE48>N1V49>C2Y50>Y3E51>N4D52>K5gap>T10V59>S14Y60>Y15
↑ Top





v1.01 @copyright 2026 UCLA